Episurf Medical to present at Life Sciencedagen on March 6, 2024

Episurf Medical (Nasdaq: EPIS B) will attend Life Sciencedagen which is held on March 6, 2024. The company will be represented by its CEO Pål Ryfors.

The presentation will be streamed live at 14:45 CET at www.lifesciencedagen.se  and will also be made available afterwards on our website www.episurf.com.

The event takes place at Wallenberg Conference Center, Sahlgrenska Academy, at Medicinareberget in Gothenburg.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

The information was submitted for publication, through the agency of the contact person set out above, at 12.30 CET on 5 March, 2024.

Tags: